As part of its program to develop contraceptive tools to control populations
of over- abundant wildlife species, the NWRC has developed a single-injection
GnRH immunocontraceptive vaccine, GonaCon™. GonaCon™ has
been tested and shown to provide contraceptive effects lasting one-three
years in many overabundant species, including white-tailed deer, domestic
and feral pigs, bison, wild horses, cats, dogs and California ground
squirrels.
The GnRH vaccine generally provided a longer-lasting contraceptive effect
in females than in males, probably because the females’ demand
for GnRH antibody is cyclic, in contrast to the males’ constant
demand. GonaCon™ contains a GnRH peptide conjugated to KLH combined
with AdjuVac™, an adjuvant also developed at NWRC.
The GnRH Vaccine Conjugate Design Developed at NWRC
A single-shot vaccine that provides a multi-year contraceptive effect
requires: (1) optimization of the vaccine structural design, (2) optimization
of the dose for each target species, (3) use of the best adjuvant available,
and (4) development of a delivery system that will protect the injected
antigen from rapid destruction by the animal’s immune system.
Multiple-shot vaccines are much less demanding with regard to optimal
vaccine design.
The design of the GnRH vaccine mimics the repetitive epitopes found
in many pathogens. Pathogenic viruses and bacteria typically exhibit
rigid, highly-organized, highly-repetitive protein epitopes. High epitope
density in a highly-organized, repetitive arrangement is important in
ß-cell responsiveness. Although ß cells are unresponsive
to repetitive epitopes that are poorly organized, repetitive epitopes
of proper spacing can stimulate multiple surface receptors of similar
spacing. The repetitive epitope pattern permits a cross-linking activation
of ß-cell receptors, providing an extremely strong, long-lasting
immune response. Mimicry of the repetitive nature of pathogen epitopes
is an important aspect of the KLH-GnRH conjugate design. The GnRH peptide,
which is analogous to the repetitive epitope, was designed to ensure
consistent alignment of the peptide when coupled to the KLH carrier.
Project
Home Page
Project
Goals and Objectives
Accomplishments
Publications
GonaCon™
GnRH
Immunocontraception (Technical Discussion)
Adjuvant
Development (Technical Discussion)
Conjugate
Design (Technical Discussion)
Nicarbazin
Diazacon
PZP
|